Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Long acting injectable
View:
Post by scarlet1967 on Feb 22, 2023 11:18am

Long acting injectable

"Turning to emerging technologies, Dr Fauci envisions the renaissance of broadly neutralizing antibodies (bnAb) for pre-exposure prophylaxis (PrEP). Despite sobering AMP trial outcomes, which tested single bnAbs, Dr Fauci pointed out that “we have to do with bnAbs what we did for ART – combine them”.  bnAb combinations could further expand the options for long-acting therapies by simultaneously targeting different epitopes on the HIV envelope or be used together with other long-acting injectables."

 

https://www.linkedin.com/posts/lifescience-dynamics-limited_hiv-hivprevention-croi2023-activity-7033499554805116930-cclT?utm_source=share&utm_medium=member_ios

 

"Patients went from taking 28 pills per day to one or two, or even a long-acting injectable, all of which reduce viral loads to undetectable levels and allow people with HIV to live near-normal lives."

Dr. Fauci to Young Scientists: Take the Ball and Run With It - Infectious Disease Special Edition

Comment by Trogarzon on Feb 22, 2023 11:24am
It does open the door ta a Trogarzo combo with Gilead for instance.. tehy know each other on top of that... maybe something happens.  Trogarzo is under appreciated at the moment and the Cantor analyst points that out.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities